Alterations in Breast Cancer Biomarkers Following Neoadjuvant Therapy

Introduction Biomarker changes in patients with residual disease (RD) after neoadjuvant systemic therapy (NAT) have unclear consequences. This study examined the prevalence of biomarker [hormone receptor (HR) and HER2] change and its effect on disease-free survival (DFS) and overall survival (OS). P...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of surgical oncology 2021-10, Vol.28 (11), p.5907-5917
Hauptverfasser:	Mohan, Srivarshini Cherukupalli, Walcott-Sapp, Sarah, Lee, Minna K., Srour, Marissa K., Kim, Sungjin, Amersi, Farin F., Giuliano, Armando E., Chung, Alice P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Breast cancer Breast Oncology ErbB-2 protein Medicine Medicine & Public Health Oncology Surgery Surgical Oncology Survival
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!